Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313254224> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W4313254224 endingPage "268" @default.
- W4313254224 startingPage "264" @default.
- W4313254224 abstract "Objective: To determine the combined cardioprotective effects of Nigella Sativa and enalapril in doxorubicininduced cardiotoxicity in rats. Study Design: Experimental randomized control trials. Place and Duration of Study: This research was carried out from September 2020 to August 2021, in the department of pharmacology, in collaboration with the National Institute of Health (NIH) Islamabad, Pakistan. Materials and Methods: For this experiment, 4 groups of adult male rats were taken, each containing 10 rats. Group 1 rats acquired a normal diet without any medication throughout the experiment. On day 8 (after acclimatization) cardiotoxicity was induced in groups 2, 3, and 4 rats by administering doxorubicin 5mg/kg intraperitoneally for 3 consecutive days. After the confirmation of cardiotoxicity, Group 3 rats were administered only angiotensin-converting enzyme inhibitors (ACEI) enalapril 2mg/kg, while group 4 rats were given a combination of Nigella sativa 100mg/kg and Enalapril 2mg/kg orally for 14 days. Baseline blood samples were taken on day 0 to obtain normal values of Cardiac Troponin T ( cTnT), Cardiac Troponin I (cTnT), and CK-MB enzyme. To confirm cardiotoxicity 2nd sampling was done on day 11, and the final sampling was done through cardiac puncture on day 26. Serum biochemical estimation was done and data were analyzed through SPSS 22 by using one-way ANOVA and paired t-test. A P-value < 0.05 was believed statistically considerable. Results: Enalapril alone produced significant cardioprotective effects as shown by the marked reduction in cTnT, cTnI, and CKMB levels in group 3 (p<0.05), but combined administration of Nigella sativa and enalapril in group 4 mice produced a more significant reduction in Trop T, Trop I, and CK-MB levels (P <0.05). Conclusion: Nigella sativa and enalapril in combination significantly lower cardiac enzyme in Doxorubicininduced cardiotoxicity in rats." @default.
- W4313254224 created "2023-01-06" @default.
- W4313254224 creator A5016769227 @default.
- W4313254224 date "2022-12-29" @default.
- W4313254224 modified "2023-10-05" @default.
- W4313254224 title "Cardioprotective Effects of Nigella Sativa and Enalapril in Doxorubicin-induced Cardiotoxicity" @default.
- W4313254224 doi "https://doi.org/10.57234/1426" @default.
- W4313254224 hasPublicationYear "2022" @default.
- W4313254224 type Work @default.
- W4313254224 citedByCount "0" @default.
- W4313254224 crossrefType "journal-article" @default.
- W4313254224 hasAuthorship W4313254224A5016769227 @default.
- W4313254224 hasBestOaLocation W43132542241 @default.
- W4313254224 hasConcept C115725540 @default.
- W4313254224 hasConcept C126322002 @default.
- W4313254224 hasConcept C27016395 @default.
- W4313254224 hasConcept C2775940317 @default.
- W4313254224 hasConcept C2776694085 @default.
- W4313254224 hasConcept C2777880890 @default.
- W4313254224 hasConcept C2778233292 @default.
- W4313254224 hasConcept C2779676291 @default.
- W4313254224 hasConcept C2781303535 @default.
- W4313254224 hasConcept C2993714443 @default.
- W4313254224 hasConcept C500558357 @default.
- W4313254224 hasConcept C556039675 @default.
- W4313254224 hasConcept C71924100 @default.
- W4313254224 hasConcept C84393581 @default.
- W4313254224 hasConcept C8880881 @default.
- W4313254224 hasConcept C98274493 @default.
- W4313254224 hasConceptScore W4313254224C115725540 @default.
- W4313254224 hasConceptScore W4313254224C126322002 @default.
- W4313254224 hasConceptScore W4313254224C27016395 @default.
- W4313254224 hasConceptScore W4313254224C2775940317 @default.
- W4313254224 hasConceptScore W4313254224C2776694085 @default.
- W4313254224 hasConceptScore W4313254224C2777880890 @default.
- W4313254224 hasConceptScore W4313254224C2778233292 @default.
- W4313254224 hasConceptScore W4313254224C2779676291 @default.
- W4313254224 hasConceptScore W4313254224C2781303535 @default.
- W4313254224 hasConceptScore W4313254224C2993714443 @default.
- W4313254224 hasConceptScore W4313254224C500558357 @default.
- W4313254224 hasConceptScore W4313254224C556039675 @default.
- W4313254224 hasConceptScore W4313254224C71924100 @default.
- W4313254224 hasConceptScore W4313254224C84393581 @default.
- W4313254224 hasConceptScore W4313254224C8880881 @default.
- W4313254224 hasConceptScore W4313254224C98274493 @default.
- W4313254224 hasIssue "4" @default.
- W4313254224 hasLocation W43132542241 @default.
- W4313254224 hasOpenAccess W4313254224 @default.
- W4313254224 hasPrimaryLocation W43132542241 @default.
- W4313254224 hasRelatedWork W1590571768 @default.
- W4313254224 hasRelatedWork W2114627331 @default.
- W4313254224 hasRelatedWork W2117663525 @default.
- W4313254224 hasRelatedWork W2132463592 @default.
- W4313254224 hasRelatedWork W2916049297 @default.
- W4313254224 hasRelatedWork W2969504066 @default.
- W4313254224 hasRelatedWork W32528152 @default.
- W4313254224 hasRelatedWork W4308740090 @default.
- W4313254224 hasRelatedWork W4313254224 @default.
- W4313254224 hasRelatedWork W4362733449 @default.
- W4313254224 hasVolume "17" @default.
- W4313254224 isParatext "false" @default.
- W4313254224 isRetracted "false" @default.
- W4313254224 workType "article" @default.